natural glp 1 and gip Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Amino acid sequences of the

Considering probiotics

: GLP principles are internationally recognized, facilitating the acceptance of non-clinical data across different countries

The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with CKD and T2DM Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, GLP-1/GIP and other metabolic hormones for the treatment of CKD At the moment the most complete data is available for semaglutide from SUSTAIN-6 and FLOW trial which is the only trial with primary renal outcome in T2DM patients out of all GLP-1 RA Very good data for renal outcomes as secondary ones available for GLP-1 RAs dulaglutide and liraglutide and GLP-1/GIP RA tirzepatide, Very interesting and positive data from mechanistic REMODEL trial with semaglutide in T2DM patients presented but not yet published (reduced perirenal fat, rernal fibrosis and much more) Based on following excellent papers: #glp1 #gip #semaglutide #tirzepatide #liraglutide #dulaglutide #kidney #ckd #chronickidneydisease #cardiovascularcomplications

GLP-1 l g v n lm g?

Focus, Drive, and Consistent Intensity

Trusted Safety & Purity Produced in a GMP-certified facility using carefully sourced, non-GMO ingredients to deliver dependable, high-quality results you can rely on with confidence.